US Broker Ratings

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: 25% Potential Upside and Strong Buy Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) continues to capture the attention of investors with its robust pipeline and promising growth prospects, evidenced by a potential upside of 25.03% based on current..

Sanofi (SNY)

⚠️ No article content returned.

..

Merck & Co., Inc. (MRK) Stock Analysis: Potential 20.80% Upside with Strong Dividend Yield Attracts Investors

Merck & Co., Inc. (NYSE: MRK), a cornerstone in the healthcare sector, continues to captivate investor interest with its robust market presence and consistent dividend payouts. With a market capitalization..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 21.74% Potential Upside for Investors

Alcon Inc. (ALC), a prominent name in the healthcare sector, stands out as a global leader in the medical instruments and supplies industry. Based in Switzerland, Alcon’s extensive portfolio spans..

Natera, Inc. (NTRA) Investor Outlook: Analyzing Its 18.11% Potential Upside

Natera, Inc. (NTRA), a prominent player in the healthcare sector, specializing in diagnostics and research, commands significant attention with a market capitalization of $23.06 billion. With a diverse portfolio of..

Royalty Pharma (RPRX) Stock Analysis: A 24% Upside Opportunity in Biotech Royalties

Royalty Pharma plc (NASDAQ: RPRX), a prominent player in the biotechnology sector, stands out as a unique investment opportunity. With a market capitalization of $21.04 billion, the company specializes in..

Biogen Inc. (BIIB) Stock Report: Unlocking a 22% Potential Upside Amid Strong Buy Ratings

Biogen Inc. (BIIB) stands as a prominent player in the healthcare sector, known for its pioneering efforts in the realm of neurological and neurodegenerative disease therapies. With a market capitalization..

Centene Corporation (CNC) Stock Analysis: Evaluating a 15.81% Potential Upside in the Healthcare Sector

In the dynamic world of healthcare plans, Centene Corporation (NYSE: CNC) stands as a significant player, offering a wide range of services to under-insured and uninsured families across the United..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 4.91% Potential Upside in the Healthcare Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a leading player in the medical devices industry, offers investors a fascinating mix of stability and growth potential within the healthcare sector. With a..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring the 8.11% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio of medical instruments and supplies. With a market capitalization..

DexCom, Inc. (DXCM) Stock Analysis: Impressive 26.79% Upside Signals Strong Potential

DexCom, Inc. (NASDAQ: DXCM), a leading player in the healthcare sector, has carved a niche for itself in the medical devices industry with its innovative continuous glucose monitoring (CGM) systems...

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 15.99% Upside Potential with Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to attract investor attention with its compelling dividend yield and a projected upside. Operating in the drug manufacturing industry,..

Cencora, Inc. (COR)

⚠️ No article content returned.

..

Bristol-Myers Squibb (BMY) Stock Analysis: Unveiling a 12.43% Upside Amid Solid Dividend Yields

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, presents an intriguing opportunity for investors looking to balance robust dividend yields with potential growth. With a market capitalization..

Boston Scientific (BSX) Stock Analysis: A Strong Buy with 15.9% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a leading force in the healthcare sector, particularly in medical devices, is capturing the attention of investors with its robust market presence and substantial growth..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling the Growth Potential with a 14% Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands at the forefront of the healthcare sector, specializing in diagnostics and research. With a market capitalization of $31.91 billion, this U.S.-based company is a..

Thermo Fisher Scientific (TMO) Stock Analysis: Exploring a 12.3% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a stalwart in the healthcare sector’s diagnostics and research industry, stands as a pivotal player in the scientific community, offering comprehensive solutions across life..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Unlocking a Potential 21% Upside Amid Strong Revenue Growth

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a powerhouse in the biotechnology sector, boasting a robust market capitalization of $101.56 billion. This Boston-based company is at the forefront of developing..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a Complex Biotech Landscape with Growth Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), headquartered in Cambridge, Massachusetts, continues to be a prominent player in the biotechnology sector, leveraging the power of ribonucleic acid interference (RNAi) to develop groundbreaking..

Haleon plc (HLN) Stock Analysis: A Potential 18% Upside in the Healthcare Sector

Haleon plc (HLN) is positioning itself as a formidable player in the global healthcare landscape. With its roots dating back to 1715, this UK-based company has developed a robust portfolio..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds